Your browser doesn't support javascript.
loading
A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.
van de Weijer, Michael L; Bassik, Michael C; Luteijn, Rutger D; Voorburg, Cornelia M; Lohuis, Mirjam A M; Kremmer, Elisabeth; Hoeben, Rob C; LeProust, Emily M; Chen, Siyuan; Hoelen, Hanneke; Ressing, Maaike E; Patena, Weronika; Weissman, Jonathan S; McManus, Michael T; Wiertz, Emmanuel J H J; Lebbink, Robert Jan.
Afiliación
  • van de Weijer ML; Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
  • Bassik MC; 1] Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA [2].
  • Luteijn RD; Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
  • Voorburg CM; Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
  • Lohuis MA; Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
  • Kremmer E; Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Molecular Immunology, 81377 Munich, Germany.
  • Hoeben RC; Department of Molecular Cell Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • LeProust EM; 1] Genomics Solution Unit, Agilent Technologies Inc., Santa Clara, California 95051, USA [2].
  • Chen S; 1] Genomics Solution Unit, Agilent Technologies Inc., Santa Clara, California 95051, USA [2].
  • Hoelen H; Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands.
  • Ressing ME; 1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2] Department of Molecular Cell Biology, Leiden University Medical Center, 2333ZC Leiden, The Netherlands.
  • Patena W; 1] Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA [2] Department of Microbiology and Immunology, University of California, San Francisco, Cal
  • Weissman JS; Department of Cellular and Molecular Pharmacology, California Institute for Quantitative Biomedical Research, Howard Hughes Medical Institute, University of California, San Francisco, California 94158, USA.
  • McManus MT; Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.
  • Wiertz EJ; 1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2].
  • Lebbink RJ; 1] Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands [2].
Nat Commun ; 5: 3832, 2014 May 08.
Article en En | MEDLINE | ID: mdl-24807418
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Virales / Antígenos de Histocompatibilidad Clase I / Proteínas de Unión al ARN / Interferencia de ARN / Enzimas Ubiquitina-Conjugadoras / Ubiquitina-Proteína Ligasas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Virales / Antígenos de Histocompatibilidad Clase I / Proteínas de Unión al ARN / Interferencia de ARN / Enzimas Ubiquitina-Conjugadoras / Ubiquitina-Proteína Ligasas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos